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Characteristics of a Family with the MEN-2A Syndrome 
Harm R. Haak,* and Arie C. Nieuwenhuijzen Kruseman 
Results of screening and follow-up in a family with the MEN-2A syndrome are described. Fourteen 
(83%) subjects at risk were affected with medullary thyroid carcinoma (MTC). Asymptomatic 
pheochromocytoma and parathyroid hyperplasia were found in two instances each. Intrathyroidal 
MTC without metastases was found in the four youngest subjects and was associated with normal basal 
but abnormal pentagastrin-stimulated calcitonin (CT) levels. In the ten subjects with abnormal basal 
CT levels, metastatic spread to at least regional lymph nodes was found. In eight ofthese ten subjects, 
total thyroidectomy with excision of affected lymph nodes and additional radioiodine did not return CT 
levels to normal postoperatively. In the other two subjects, the CT levels returned to normal after 
thyroidectomy and an ablative dose of radioiodine, and remained normal during follow-up. This study 
confirms the view that family screening at a young age promotes the detection of MTC at a curable 
stage. Radioiodine as an adjunct to surgery may be ofvalue in the prevention of tumor recurrence in 
patients with normal postoperative CT levels but residual thyroid tissue. (Henry Ford Hosp Med J 
1987:35:104-6) 
In 1980 we studied a newly discovered family with the MEN-2A syndrome. The index case was a 45-year-old woman (#6, Fig 1) 
with a locally invasive medullary thyroid carcinoma (MTC), but 
no signs or symptoms suggestive of hyperparathyroidism and/or 
pheochromocytoma. Her father had died at age 46 from a pheo-
chromocytoma. A unilateral pheochromocytoma had been 
removed from her sister in 1969 at the age of 22. After total 
thyroidectomy, the patients with MTC received an ablative dose 
of ' ^ ' I to irradiate normal, hyperplastic, and neoplastic C-cells 
adjacent to iodine-trapping follicular cells present in residual 
thyroid tissue (1). 
The follow-up had two objectives: 1) to evaluate the prog-
nostic value of basal and pentagastrin-stimulated calcitonin 
(CT) levels on the outcome of MTC, and 2) to evaluate the ef-
fects of " ' I on residual MTC and on prevention of recurrence. 
Patients and Methods 
We studied 21 members of the pedigree shown in Fig 1 (pa-
tient #11 who lives in Canada where he had an operation for 
MTC is not included in our study group). Evaluation included a 
medical history, clinical examination, and measurement of basal 
CT (n < 14 pmol/L) and pentagastrin-stimulated CT (n < 40 
pmol/L), carcinoembryonic antigen (CEA), calcium, phos-
phate, alkaline phosphatase in plasma, and 24-hour urinary 
excretion of V M A (1). 
Total thyroidectomy was performed in those patients with 
abnormal basal and/or pentagastrin-stimulated CT levels. 
Cervical lymph nodes that appeared abnormal on palpation and 
macroscopic examination were resected. Two weeks after thy-
roidectomy, provocative testing with pentagastrin was repeated 
and a 24-hour uptake of a 1 mCi tracer dose of ' ^ ' I and thyroid 
scan were performed. An ablative dose of ' ^ ' I was administered 
orally with standard radiation precautions. Three months later. 
thyroid replacement was withdrawn for four weeks, and the thy-
roid scan with a tracer dose of 1 mCi ' ^ ' I was repeated. The eval-
uation was repeated at that time and at yearly intervals. 
Results 
The pedigree is given in Fig 1. Apart from the index case 
(#6), 14 (83%) of the family members at risk had MTC at first 
screening, although none had presented clinically. In our studies 
abnormal CT levels were found in five of seven siblings of the 
index patient and eight of nine members of the next generation. 
Nine of these 13 individuals (mean age 28, range 13 to 43) had 
raised basal CT levels, and four (mean age 9.5, range nine to 11 
years) had elevated levels only after pentagastrin stimulation. 
The CEA level was abnormal in six of the nine patients with ele-
vated basal CT levels. In all cases the MTC was multicentric, 
and all patients with increased basal CT levels had lymph node 
involvement. Postoperative basal and pentagastrin-stimulated 
CT levels became normal in two of nine patients with pre-
operatively abnormal basal CT levels and in all four patients 
with preoperatively abnormal pentagastrin-stimulated CT levels 
only (Fig 2). After thyroidectomy, residual thyroid tissue was 
demonstrated by ' ^ ' I uptake in all patients, and therefore all re-
ceived an ablative dose of '-""I (50 to 75 mCi ' ^ ' I sodium iodide) 
in an attempt to destroy normal and abnormal C-cells adjacent to 
follicular cells in the residual thyroid tissue. 
The results of investigations to detect parathyroid and adrenal 
abnormalities were normal at first presentation. Nevertheless, 
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Fig 1—Pedigree. 
parathyroid enlargement was found in two patients during thy-
roidectomy. The results of microscopy of the removed para-
thyroids were consistent with hyperplasia. 
Follow-up 
In all but one of the patients whose CT levels were elevated 
postoperatively, the CT levels remained elevated during follow-
up (Fig 3), The exception was the index patient (#6, Fig 1) in 
whom CT and CEA levels gradually decreased to the normal 
range. In the patients whose basal and pentagastrin-stimulated 
CT levels were normal postoperatively, these levels remained 
within the normal range (Fig 3), with the exception of patient 
#20 (Fig 1), whose last basal CT value was slightly elevated (21 
pmol/L) but whose pentagastrin-stimulated CT level was nor-
mal. None ofthe operated patients has had any clinical sign of 
residual or recurrent MTC. 
Recently, abdominal computed tomography was performed 
in patients #6, #8, #9, and #13. These patients had normal 
urinary excretion of VMA and no symptoms suggestive for pheo-
chromocytoma except for patient #9 who presented with 
atypical paroxysms but normal blood pressure. 
In two of these patients, computed tomography revealed 
a unilateral (patient #6) and bilateral (patient #9) pheo-
chromocytoma. The presence of pheochromocytomas was 
further substantiated by elevated plasma catecholamine levels 
nonsuppressible after clonidine (2) and positive meta-iodo-ben-
zylguanidine (MIBG) scans. Patient #9 underwent a bilateral 
adrenalectomy after which the paroxysms subsided. Patient #6 
refused adrenalectomy because of the absence of symptoms 
related to pheochromocytoma. 
Discussion 
Our experience confirms the generally accepted view (3-5) 
that screening in MEN-2 family members at a young age pro-
motes the identification of early MTC at a curable stage. An ab-
normal basal CT level according to our assay criteria suggests 
metastases to at least the regional lymph nodes. A normal basal 
but abnormal pentagastrin-sfimulated CT level suggests intra-
thyroidal disease which has not yet metastasized. 
The observation of metastases in at least regional lymph 
nodes in young subjects with only moderate increases of basal 
CT levels and no palpable disease agrees with many other re-
ports that early metastatic spread is common (6,7). In most of 
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Fig 2—Basal and peak pentagastrin-stimulated CT values be-
fore surgery at listed ages. (Solid circles represent individuals 
whose stimulated CT levels became normal postoperatively. 
Open circles indicate those who had elevated values 
postoperatively.) 
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Fig 3—Serial basal and peak pentagastrin-stimulated CT 
values postoperatively and during follow-up after wa* 
administered shortly after the postoperative testing. 
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these patients the CT levels remained abnormal after total thy-
roidectomy and excision of affected lymph nodes, which might 
imply that our surgical procedure was inadequate for cure. Be-
cause of similar experiences in other studies (6,7), we recom-
mend total thyroidectomy plus at least regional lymphadenec-
tomy with modified radical lymph node dissection at the site of 
macroscopic metastases. However, in many cases this procedure 
is also not curative. 
Since C-cells do not trap iodine, radioiodine treatment is not a 
usual adjunct to surgery in the management of residual sporadic 
and hereditary MTC (1,6). However, since normal and probably 
also hyperplastic C-cells are very sensitive to radiation from '^ ' I 
accumulated in adjacent follicular cells (7), and since total thy-
roidectomy is virtually always incomplete, radioiodine may 
help prevent the development of MTC from residual C-cells, In 
the family presented here, no clinical tumor recurrence has been 
found during a follow-up period of seven years, whereas in other 
series tumor recurrences after complete thyroidectomy alone 
have been reported (6,7), Longer follow-up data are clearly 
necessary before we conclude that radioiodine is indeed useful 
as an adjunct to surgery in patients who also have normal 
postoperative CT levels but scintigraphically identified residual 
thyroid fissue. 
Pheochromocytoma in MEN-2A patients usually presents in-
sidiously and is difficuh to detect at an early stage. We identified 
two patients with pheochromocytomas who did not have typical 
clinical symptoms or elevated urinary excretions of VMA, More 
advanced biochemical and radiological techniques are 
warranted before one can conclude that pheochromocytoma 
is absent. 
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"Communication is the Cape Canaveral of the scholar. The product of 
curiosity must be launched from the pad or it serves no purpose." 
George A. Perera 
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